New study results presented at AUA2023 concluded similar oncological outcomes between radical cystectomy (RC) and trimodal therapy (TMT) for select cT2-cT4 muscle invasive bladder cancer patients. Find out more in this interview with Dr. Alexandre Zlotta.
